We are live on ! Find out more
TCM

Tang Capital Management Portfolio holdings

AUM $1.97B
1-Year Est. Return 125.1%
This Fund
S&P 500
This Quarter Est. Return
-11.42%
1 Year Est. Return
+125.1%
3 Year Est. Return
+474.48%
5 Year Est. Return
+595.08%
10 Year Est. Return
+2,831.44%
AUM
$271M
AUM Growth
-$58.4M
Cap. Flow
-$36.9M
Cap. Flow %
-13.63%
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
1
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
OPK icon
Opko Health
OPK
+$32.8M
2
LJPC
La Jolla Pharmaceutical Company
LJPC
+$7.88M

Top Sells

Rank Stock Value
1
BRLI
BIO-REFERENCE LABS INC-NEW-
BRLI
+$37.1M

Sector Composition

Rank Sector Weight
1 Healthcare 91.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRTX icon
1
Heron Therapeutics
HRTX
$86.3M
$127M 46.71%
5,190,837
– –
LJPC
2
DELISTED
La Jolla Pharmaceutical Company
LJPC
$81M 29.87%
2,914,970
+250,000
+9% +$7.88M
OPK icon
3
Opko Health
OPK
$921M
$20.8M 7.68%
+2,475,000
New +$32.8M
BMRN icon
4
BioMarin Pharmaceuticals
BMRN
$11.5B
$19.2M 7.08%
182,300
– –
BRLI
5
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
– –
-900,000
Closed -$37.1M

Similar funds

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return
CCA
Checchi Capital Advisers Beverly Hills, California $1.98B AUM 19.17% 1-Year Est. Return
FWTB
First Western Trust Bank Denver, Colorado $1.98B AUM 1.62% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return

Tang Capital Management's Q3 2015 Portfolio in Review

As of Q3 2015, Tang Capital Management held 7 positions worth $271M, down 18% from $330M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tang Capital Management withdrew a net $36.9M in Q3 2015, closing 1 position. Its most notable exit was BIO-REFERENCE LABS INC-NEW-, an estimated $37.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, up from 76% a quarter earlier.

Against the trend, Tang Capital Management opened a new position in Opko Health worth $20.8M.

  • Tang Capital Management's largest Q3 2015 buy was Opko Health: 2,475,000 shares worth $20.8M.
  • Tang Capital Management added most to La Jolla Pharmaceutical Company in Q3 2015, an estimated $7.88M increase.
  • Tang Capital Management fully exited BIO-REFERENCE LABS INC-NEW- in Q3 2015, selling an estimated $37.1M.
  • Tang Capital Management's ten largest holdings make up 100% of its $271M portfolio in Q3 2015.
  • Tang Capital Management opened 1 new position and closed 1 in Q3 2015.
  • Tang Capital Management's portfolio value fell 18% quarter-over-quarter to $271M.

Based on Tang Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.